Company Overview

Development Stage

  • Stage: IPO上市, 创业板, 深交所。
  • Ranking: Ranked #12 in Chamdo by popularity
  • News: 2025-04-22:多瑞医药:子公司获得复方醋酸钠林格注射液药品注册证书。
  • Salary: 52% of positions earn 6-10K, In 2026 vs last yeardecreased by 5%.。Master's salary: ¥12.5K.
  • Recruiting: In 2026 vs 2025grew by 38%. Demand for highly educated talent: Master's: 2.
  • Requirement: Education: 本科 leads with 44%. Experience: 不限 leads with 76%.
  • Region: Distributed across 2 regions, 北京: 60%, 成都: 24%, 武汉: 12%, 襄阳: 4%.

About the Company

[Summary] 高端仿制药及改良型创新药

西藏多瑞医药股份有限公司(股票代码301075)成立于2016年,位于西藏自治区昌都市经济技术开发区,是西藏本土上市化学制药企业,2021年登陆深圳证券交易所创业板。公司采用制剂+多肽原料药+精细化工中间体三业务并行的原料制剂一体化运营模式。多肽原料药板块由全资子公司四川多瑞运营,拥有GMP标准生产基地,布局艾博韦泰、司美格鲁肽等核心品种;同时推进特色中药藏药研发,1类中药新药益肺济生颗粒已完成二期临床入组。公司构建有机合成、多肽合成双研发团队,截至2024年末拥有38项专利,2025年研发投入占营收比例达21.02%。未来将聚焦核心赛道,做强多肽产能,持续提升市场竞争力。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

多瑞医药 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

多瑞医药 How Fast Is Hiring Growing? (21 open positions)

Manage
Note: How fast is hiring at 西藏多瑞医药股份有限公司 growing? 多瑞医药2026: 22 openings (up 38%), 2025: 16 openings (up 7%), 2024: 15 openings (down 53%), 2023: 32 openings (up 167%), 2022: 12 openings (down 73%), 2021: 44 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

多瑞医药 Master's Degree Job Demand Analysis

(More)
多瑞医药 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 西藏多瑞医药股份有限公司 growing? 多瑞医药Master's recruitment over the years: 2025: 1 openings (up 7%), 2022: 4 openings (down 73%), 2021: 3 openings.

多瑞医药 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
多瑞医药 Doctoral Hiring by Year: 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 西藏多瑞医药股份有限公司 growing? 多瑞医药Doctorate recruitment over the years: 2025: 1 openings (up 7%), 2022: 1 openings (down 73%), 2021: 2 openings.

多瑞医药 — What Are the Salaries Like? (25 records)

Manage
salary range: 2K - 20K, 52% of roles pay ¥6-10K
Note: salary statistics are based on 25 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 西藏多瑞医药股份有限公司?多瑞医药52% of positions earn 6-10K, Fresh graduate salary: ¥2.5K。Chamdo salary ranking: #6,客户服务类 average salary ¥8.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 多瑞医药

(More)
Are salaries high at 西藏多瑞医药股份有限公司? We provide: 行政,实习生,人事,养护员,研究员,证券,财务,销售,pi,会计,信息,司机,外贸经理,帮厨,接待,有机合成,生活助理,管家. Click to view detailed salary analysis by job.

多瑞医药 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 客户服务类
    16% of total 16%
  • 经营管理类
    16% of total 16%
  • 行政/后勤类
    16% of total 16%
  • 其他(研发和技术类)
    12% of total 12%

Education

  • 本科
    44% of total 44%
  • 大专
    28% of total 28%
  • 不限
    12% of total 12%
  • 高中
    8% of total 8%

Experience

  • 不限
    76% of total 76%
  • 3-5年
    12% of total 12%
  • 应届生
    4% of total 4%
  • 1-3年
    4% of total 4%
View Detailed Analysis

What does 西藏多瑞医药股份有限公司 require? Who is 多瑞医药 hiring? 多瑞医药 recruitment: 客户服务类占比最多占16%,其次是经营管理类占16%. What education can get in at 多瑞医药? 本科占比最多占44%,其次是大专占28%. High education required at 多瑞医药? 硕士占8%. Work experience required at 多瑞医药? 不限占比最多占76%,其次是3-5年占12%. Where are the job locations at 多瑞医药? 北京占比最多占60%,其次是成都占24%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 8,000万(元)
Legal Representative: 王庆太
Date Established:
Credit Code: 91540300MA6T1TRQ34
Registered Address: 西藏自治区昌都市经济技术开发区A区创业大道9号

Partners & Suppliers

多瑞医药向其受让盐酸奈福泮原料药及注射液技术 Source
供应商 研发服务
为多瑞医药提供盐酸纳洛酮注射液委托生产服务 Source
供应商 委托生产服务
为多瑞医药提供市场推广服务 Source
供应商 市场推广服务
为多瑞医药提供市场推广服务 Source
供应商 市场推广服务
为多瑞医药提供市场推广服务 Source
供应商 市场推广服务

People who follow 多瑞医药 also follow

多瑞医药 Competitors (Similar Companies)

医药 生物制品 诊断试剂 生物医药
“Poly benefits the world, health benefits all”
生化药品 生产 生物分离 原料
“Low-cost, high-quality mobile diagnostic and testing tools for familie”
医药 制药/药业 药物研发 生物医药
“A high-tech enterprise specializing in the research and development, p”
医药 药物研发 生物医药 生物制药
“使命:引领行业发展,开创品质生活,倡导健康快乐理念”
“A platform-based service provider in the life science service field”
“中国医药工业化药百强”
“Research and development of recombinant protein drugs and microecologi”
过程装备 材料科技 工业 高分子化学
“A high-tech enterprise specializing in drug R&D”
环保科技 检测 电磁辐射 环境治理
“生物样本冷冻保存平台”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates